+ + data and comments + +, page-10

Thanks sKaTiNg_ANd_GirLS_DonT_mIx.

Interesting that Hunter has upgraded PLG to a buy.

Melanoma is one of a few diseases where treatment agents fear to thread.

Treatments have been in the main massive failures. It is the metastasis (migration of tumour cells) which makes it a deadly disease.

I am not sure how much Taxotere (chemo) they will be using in the combo P-88 drug.

NRT have found that that their combination Phenoxodiol + Cisplatin (chemo) uses only a fraction of the latter. They will be using it on another feared cancer: Ovarian.

I need to find out the dose PLG will be using in the US Melanoma Phase II trial.
_____________________________________

Thanks for the information, Redgumme; I am quite happy being a shareholder of both PLG and SPL.

Gerry